| Melissa Wright, FNP-BC | |
|
6286 Stonebridge Dr, Fairview, PA 16415-3508 | |
| (716) 424-8680 | |
| Not Available |
| Full Name | Melissa Wright |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 6286 Stonebridge Dr, Fairview, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770221251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 349141 (New York) | Primary |
| Entity Name | Wellnow Urgent Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669825162 PECOS PAC ID: 8325320864 Enrollment ID: O20170118001953 |
News Archive
In the body's ongoing effort to maintain a healthy weight, an arsenal of cellular proteins called androgen receptors is critical for blocking fat accumulation. Now researchers reporting in the September issue of the Cell Press Journal Chemistry & Biology have discovered that naturally occurring steroids called glucocorticoids can thwart the receptors' activity, ultimately encouraging fat buildup.
Health insurance plans offered in Massachusetts and analyzed by U.S. News & World Report were found to be among the most comprehensive in the country. The analysis included 67 plans from four Massachusetts insurers that are sold to individuals or families. Each earned at least four of five stars based on scope of coverage and cost to consumers. In other states, the portion of plans with the higher rankings ranged from 4 percent in Washington to 94 percent in New York.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
Health care "is rising on the national agenda, but at least four things need to happen for this debate not to end in failure in the new Congress in 2009, as the last debate did in 1994," Drew Altman, president and CEO of the Kaiser Family Foundation, writes in a Boston Globe opinion piece.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Wright, FNP-BC 6286 Stonebridge Dr, Fairview, PA 16415-3508 Ph: (716) 424-8680 | Melissa Wright, FNP-BC 6286 Stonebridge Dr, Fairview, PA 16415-3508 Ph: (716) 424-8680 |
News Archive
In the body's ongoing effort to maintain a healthy weight, an arsenal of cellular proteins called androgen receptors is critical for blocking fat accumulation. Now researchers reporting in the September issue of the Cell Press Journal Chemistry & Biology have discovered that naturally occurring steroids called glucocorticoids can thwart the receptors' activity, ultimately encouraging fat buildup.
Health insurance plans offered in Massachusetts and analyzed by U.S. News & World Report were found to be among the most comprehensive in the country. The analysis included 67 plans from four Massachusetts insurers that are sold to individuals or families. Each earned at least four of five stars based on scope of coverage and cost to consumers. In other states, the portion of plans with the higher rankings ranged from 4 percent in Washington to 94 percent in New York.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
Health care "is rising on the national agenda, but at least four things need to happen for this debate not to end in failure in the new Congress in 2009, as the last debate did in 1994," Drew Altman, president and CEO of the Kaiser Family Foundation, writes in a Boston Globe opinion piece.
› Verified 9 days ago
Allison Mailliard, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7287 W Ridge Rd, Fairview, PA 16415 Phone: 814-877-2360 | |
Dr. Richard Sy Sposito, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7686 West Ridge Rd., Fairview, PA 16415 Phone: 814-474-2654 Fax: 814-474-2656 | |
Dr. Richard Anthony Ortoski, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7686 West Ridge Road, Fairview, PA 16415 Phone: 814-774-3191 Fax: 814-774-0681 | |
Brian Joseph Stark, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7287 W Ridge Rd, Fairview, PA 16415 Phone: 814-877-2360 Fax: 814-474-3561 | |
Thomas H Turner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7176 W Ridge Rd, Fairview, PA 16415 Phone: 814-474-3613 Fax: 814-474-3537 | |
Michael Spellacy, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7287 W Ridge Rd, Fairview, PA 16415 Phone: 814-877-2360 |